LSE:GSKPharmaceuticals
Is GSK’s 34% 2025 Rally Justified by Cash Flow and Earnings Prospects?
If you have been wondering whether GSK is still good value after its strong run, you are not alone. This piece will walk through what the current share price might really be implying.
With the stock at around £18.26 and up 1.3% over the last week, 2.0% over the past month, and 34.1% year to date, the recent momentum suggests investors are reassessing both its growth prospects and risk profile.
Recent headlines have focused on GSK sharpening its focus on vaccines and specialty medicines,...